EBMT 2024 | The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri
• 15 Apr 2024
Mattia Algeri, MD, Bambino Gesù Children’s Hospital, Rome, Italy, discusses the importance of the multi-disciplinary team (MDT) in the new era of treating hemoglobinopathies with autologous gene editing techniques. Dr Algeri emphasizes collaboration among physicians, nurses, and psychologists to fully educate patients on the treatment process, including explaining gene therapy benefits post-transplant compared to allogeneic stem cell transplantation (alloSCT). This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Vertex: Advisory Board.
